Mitochondrial signal
MOTS-c originates from mitochondrial genetic information and participates in communication between mitochondrial state and cellular regulation.
NXP / 04
Research profile
MOTS-C
40MGMitochondrial-derived peptide research material
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region of mitochondrial DNA. It is studied as a mitochondria-to-nucleus signal involved in metabolic adaptation and cellular stress responses.
Scientific context
What it does.
MOTS-c research examines glucose utilisation, metabolic flexibility, AMPK-linked signalling, exercise response and cellular adaptation to energetic stress. Much of the intervention evidence remains preclinical, so model, tissue and assay selection materially affect interpretation.
Mechanism map
How the research
model works.
Energy-sensing pathway
Experimental work links MOTS-c with AMPK activation and changes in folate and purine metabolism during energetic stress.
Nuclear stress response
Under metabolic stress, MOTS-c has been reported to translocate to the nucleus and influence adaptive gene expression.
Study design
Research pairing
options.
These are experimental design concepts—not recommendations for human use, co-administration or dosing.
NAD+ research arm
Supports a factorial design comparing mitochondrial signalling with cellular redox and cofactor availability.
Direct NAD+ exposure and MOTS-c signalling are distinct variables and require separate arms.Retatrutide comparator
Separates intracellular energy-stress signalling from receptor-level metabolic agonism.
Avoid interpreting overlapping metabolic endpoints as proof of synergy.Unstacked control
A MOTS-c-only arm best attributes AMPK, transcriptomic and substrate-use changes to the test article.
Include time-matched vehicle and stress-condition controls.Interpretation controls
Important
limitations.
- A large proportion of efficacy evidence is derived from cell and animal models.
- Endogenous MOTS-c measurement and exposure to synthetic material answer different research questions.
- Tissue, metabolic state, timing and assay platform can substantially change observed endpoints.
Evidence trail